Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Because of its great potential for diversity, the immunoglobulin heavy chain complementarity-determining region 3 (HCDR3) is taken as an antibody molecule’s most important component in conferring binding activity and specificity. For this reason, HCDR3s have been used as unique identifiers to investigate adaptive immune responses in vivo, and to characterize in vitro selection outputs where display systems were employed. Here we show that many different HCDR3s can be identified within a target specific antibody population after in vitro selection. For each identified HCDR3 a number of different antibodies bearing differences elsewhere can be found. In such selected populations, all antibodies with the same HCDR3 recognize the target, albeit at different affinities. In contrast, within unselected populations, the vast majority of antibodies with the same HCDR3 sequence do not bind the target. In one HCDR3 examined in depth, all target-specific antibodies were derived from the same VDJ rearrangement, while non-binding antibodies with the same HCDR3 were derived from many different V and D gene rearrangements. Careful examination of previously published in vivo datasets reveals that HCDR3s shared between, and within, different individuals can also originate from rearrangements of different V and D genes, with up to 26 different rearrangements yielding the same identical HCDR3 sequence. Based on these observations we conclude that the same HCDR3 can be generated by many different rearrangements, but that specific target binding is an outcome of unique rearrangements and VL pairing: the HCDR3 is necessary, albeit insufficient, for specific antibody binding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diversity in the CDR3 Region of VH Is Sufficient for Most Antibody Specificities
Xu, J. L., & Davis, M. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00006-6 · Cited by 779
A new clustering of antibody CDR loop conformations
North, B., Lehmann, A., & Dunbrack, R. L. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.030 · Cited by 380 · cited 1×
“Although the other antibody-binding loops have defined canonical structures (32–35), the prediction of the HCDR3 conformation is not trivial and has been found to have a wide variety of different possible configurations (35).”
Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
Jiang, N., He, J., Weinstein, J. A., Penland, L., Sasaki, S., He, X.-S., Dekker, C. L., Zheng, N.-Y., Huang, M., Sullivan, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004794 · Cited by 335 · cited 1×
“…widely applied to many areas of human immunology, helping, for instance, to increase understanding of antibody repertoires (64–71), VH/VL pairing (39, 67), humoral responses to pathogens (72–74), vaccination (41, 73, 75, 76), and the role of antibodies in autoimmune conditions (77) and cancer (78).”
Gram, H., Marconi, L. A., Barbas, C. F., Collet, T. A., Lerner, R. A., & Kang, A. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3576 · Cited by 307
Busse, C. E., Czogiel, I., Braun, P., Arndt, P. F., & Wardemann, H. (2014) · European Journal of Immunology · doi:10.1002/eji.201343917 · Cited by 121 · cited 1×
“Next-generation sequencing has been widely applied to many areas of human immunology, helping, for instance, to increase understanding of antibody repertoires (64–71), VH/VL pairing (39, 67), humoral responses to pathogens (72–74), vaccination (41, 73, 75, 76), and the role of antibodies in autoimmune conditions (77)…”
Cited by
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Understanding the human antibody repertoire
Rees, A. R. (2020) · mAbs · doi:10.1080/19420862.2020.1729683 · Cited by 108
“In 2018D’Angelo et al.72 observed thatmany different combinatorial rearrangements can give rise to the same heavychain CDR3 sequence, and that when that sequence is in the context of a specific VH-DH-JH recombination, target specificity is achieved.”
BackgroundResultInfluentialSalem, G. M., Galula, J. U., Wu, S.-R., Liu, J.-H., Chen, Y.-H., Wang, W.-H., Wang, S.-F., Song, C.-S., Chen, F.-C., Abarientos, A. B., et al. (2024) · Communications Biology · doi:10.1038/s42003-023-05661-w · Cited by 14
Kumar, A., Duffieux, F., Gagnaire, M., Rapisarda, C., Bertrand, T., & Rak, A. (2024) · Nature Communications · doi:10.1038/s41467-024-53746-9 · Cited by 11
Metadata
- Authors
- D’Angelo, S., Ferrara, F., Naranjo, L., Erasmus, M. F., Hraber, P., & Bradbury, A. R. M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-08
- Volume
- 9
- Pages
- 395-395
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2789588180
- Cited by
- 95
- References
- 5
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding. https://app.cochat.ai/papers/10.3389/fimmu.2018.00395
- The paper
- D’Angelo, S., Ferrara, F., Naranjo, L., Erasmus, M. F., Hraber, P., & Bradbury, A. R. M. (2018). Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.00395
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.